Vir Biotechnology, Inc.

NASDAQ:VIR

Biotechnology

Healthcare
$9.15 -2.63%

-$0.25 today

Market cap
$1.57B
Beta
1.64
P/E (TTM)
-3.0
EPS (TTM)
-$3.00
52W Low $4.16High $11.66

Volume 2.15M

Average 1.76M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.00B

FY 2025 · Annual

-28.3% YoY

Liabilities

$237.55M

FY 2025 · Annual

-4.4% YoY

Equity

$765.28M

FY 2025 · Annual

-33.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents347.82M848.63M241.58M222.95M234.11M
Short-term Investments360.33M1.55B1.28B682.4M228.75M
Net Receivables773.08M0003.6M
Inventory00000
Other Current Assets8.59M59.2M65.82M137.11M47.62M
Total Current Assets1.56B2.52B1.59B1.04B514.08M
Property, Plant & Equipment (Net)130.05M188.17M167.2M122.86M117.72M
Goodwill16.94M16.94M16.94M16.94M16.94M
Intangible Assets33.29M32.76M22.57M8.1M7.85M
Long-term Investments201.39M23.93M105.28M190.02M314.58M
Tax Assets0249.72M000
Other Non-current Assets9.78M(228.5M)18.86M18.42M31.66M
Total Non-current Assets391.45M283.01M330.83M356.33M488.74M
Total Assets1.95B2.8B1.92B1.4B1B
Account Payables6.52M6.42M6.33M5.08M9.8M
Short-term Debt00008.8M
Tax Payables6.22M15.23M149K00
Deferred Revenue98.21M15.52M64.85M12.65M0
Other Current Liabilities07.65M9.35M16.06M74.21M
Total Current Liabilities341.24M511.03M175.41M119.66M92.82M
Long-term Debt000089.05M
Deferred Tax Liabilities18.44M3.25M000
Deferred Revenue (Non-current)3.82M53.21M1.53M00
Other Non-current Liabilities25.36M32.8M40.22M38.63M(33.38M)
Total Non-current Liabilities181.18M213.1M153.42M128.77M144.73M
Total Liabilities522.42M724.13M328.82M248.43M237.55M
Common Stock13K13K13K14K14K
Retained Earnings(138.6M)377.24M(237.82M)(759.78M)(1.2B)
Accumulated OCI(1.1M)(9.12M)(815K)(1.72M)(2.06M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.43B2.08B1.59B1.15B765.28M
Total Debt137.49M127.97M124.54M97.89M186.91M
Net Debt(210.33M)(720.66M)(117.04M)(125.06M)(47.2M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$276.1M
Short-term Investments$196.3M
Other Current$50.6M
Total Current Assets$523.0M
PP&E (Net)$113.9M
Goodwill$16.9M
Intangible Assets$7.8M
Long-term Investments$333.0M
Other Non-current$31.0M
Total Non-current Assets$502.6M
Total Assets$1.0B

Analysis

Selected assets total $1.0B for Latest. The largest visible component is Long-term Investments at $333.0M, about 32.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
424B5424B5 filingNov 12, 2026
S-3ASRS-3ASR filingNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 9, 2026
SC 13D/ASC 13D/A filingNov 6, 2026

How much cash does VIR have?

Vir Biotechnology, Inc. (VIR) reported $234.11M in cash and equivalents in fiscal 2025.

How much debt does VIR carry?

Vir Biotechnology, Inc. (VIR) reported $186.91M of total debt, with net debt of -$47.20M.